136 related articles for article (PubMed ID: 6366675)
1. [Therapeutic response of various histological osteosarcoma subtypes to high-dose methotrexate treatment].
Schulz A; Fischer HP; Breithaupt H; Pralle H
Onkologie; 1983 Dec; 6(6):296-304. PubMed ID: 6366675
[TBL] [Abstract][Full Text] [Related]
2. [The results of using high-dose methotrexate in treating osteogenic sarcoma].
Perevodchikova NI; Eremina LA; Manziuk LV; Siniukov PA; Fedenko AN; Singin AS; Moldovanova LK
Vopr Onkol; 1990; 36(6):667-71. PubMed ID: 2378085
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of low-dose methotrexate in advanced osteosarcoma followed by escalation after disease progression: a study of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research on Treatment of Cancer.
Wagener DJ; van Oosterom AT; Mulder JH; Somers R; Mouridsen HT; Cortes Funes H; Thomas D; Sylvester R
Cancer Treat Rep; 1986 May; 70(5):615-8. PubMed ID: 3458532
[TBL] [Abstract][Full Text] [Related]
4. Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases.
Marroum MC; Huvos AG; Rosen G
Oncology; 1977; 34(6):273-80. PubMed ID: 304199
[TBL] [Abstract][Full Text] [Related]
5. Selected applications of methotrexate alone and in combination in osteosarcoma.
Pratt CB
Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy?
Bacci G; Picci P; Gherlinzoni F; Van Horn JR; Orlandi M; Normand AR; Manfrini M; Pignatti G; Campanacci M
Chemioterapia; 1986 Apr; 5(2):140-3. PubMed ID: 3458546
[TBL] [Abstract][Full Text] [Related]
7. Massive pulmonary tumor emboli in osteosarcoma. Occult and fatal complication.
Wakasa K; Sakurai M; Uchida A; Yoshikawa H; Maeda A
Cancer; 1990 Aug; 66(3):583-6. PubMed ID: 2364369
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patients.
Tunn PU; Reichardt P
Onkologie; 2007 May; 30(5):228-32. PubMed ID: 17460416
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.
Bacci G; Ferrari S; Delepine N; Bertoni F; Picci P; Mercuri M; Bacchini P; Brach del Prever A; Tienghi A; Comandone A; Campanacci M
J Clin Oncol; 1998 Feb; 16(2):658-63. PubMed ID: 9469355
[TBL] [Abstract][Full Text] [Related]
10. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.
Bajpai J; Chandrasekharan A; Talreja V; Simha V; Chandrakanth MV; Rekhi B; Khurana S; Khan A; Vora T; Ghosh J; Banavali SD; Gupta S
Eur J Cancer; 2017 Nov; 85():49-58. PubMed ID: 28888849
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for osteogenic sarcoma: an investigative method, not a recipe.
Rosen G; Nirenberg A
Cancer Treat Rep; 1982 Sep; 66(9):1687-97. PubMed ID: 6981454
[No Abstract] [Full Text] [Related]
12. Pathological responses to preoperative high-dose methotrexate chemotherapy in osteosarcoma--experience in Korea cancer hospital.
Lee SY; Jeon DG; Kim SS; Jang JJ; Cho KJ
J Korean Med Sci; 1993 Apr; 8(2):121-6. PubMed ID: 8397928
[TBL] [Abstract][Full Text] [Related]
13. Disparate histologic responses in simultaneously resected primary and metastatic osteosarcoma following intravenous neoadjuvant chemotherapy.
Nachman J; Simon MA; Dean L; Shermeta D; Dawson P; Vogelzang NJ
J Clin Oncol; 1987 Aug; 5(8):1185-90. PubMed ID: 2442316
[TBL] [Abstract][Full Text] [Related]
14. [Results of treatment of osteosarcoma in children according to the SFOP-94 protocol in the experience of the Polish Paediatric Solid Tumour Study Group].
Chybicka A; Jaworski W; Liebhart M; Gołebiowski W; Kazanowska B; Wecławek-Tompol J; Woźniak W; Kijowski J; Kowalczyk J; Katski K; Kołecki P; Boruczkowski D; Leda M
Med Wieku Rozwoj; 2000; 4(1 Suppl 2):91-6. PubMed ID: 12021467
[TBL] [Abstract][Full Text] [Related]
15. Primary osteosarcoma of bone. Clinicopathologic investigation of 243 cases, with necropsy studies in 54.
Uribe-Botero G; Russell WO; Sutow WW; Martin RG
Am J Clin Pathol; 1977 May; 67(5):427-35. PubMed ID: 266360
[TBL] [Abstract][Full Text] [Related]
16. Multifocal osteosarcoma in childhood.
Kunze B; Bürkle S; Kluba T
Chir Organi Mov; 2009 May; 93(1):27-31. PubMed ID: 19711159
[TBL] [Abstract][Full Text] [Related]
17. [Neoadjuvant chemotherapy for osteosarcoma].
Guo W; Yang RL; Tang XD; Tang S; Li DS; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1186-90. PubMed ID: 15387981
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging (MRI) in evaluating in vivo response to neoadjuvant chemotherapy for osteosarcomas of the extremities.
Hogeboom WR; Hoekstra HJ; Mooyaart EL; Oosterhuis JW; Postma A; Veth RP; Schraffordt Koops H
Eur J Surg Oncol; 1989 Oct; 15(5):424-30. PubMed ID: 2792393
[TBL] [Abstract][Full Text] [Related]
20. Metastatic osteosarcoma.
Daw NC; Billups CA; Rodriguez-Galindo C; McCarville MB; Rao BN; Cain AM; Jenkins JJ; Neel MD; Meyer WH
Cancer; 2006 Jan; 106(2):403-12. PubMed ID: 16353204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
